Occurrence of Selected Generic Drugs 2

    Basic Details
    Date Posted
    Thursday, August 2, 2012
    Status
    Complete
    Medical Product
    acitretin
    acitretin/emollient combo. 26
    ambrisentan
    bosentan
    busulfan
    chlorambucil
    clarithromycin
    cyclophosphamide
    dronedarone
    finasteride
    fluconazole
    isotretinoin
    lenalidomide
    lisinopril
    lisinopril/hydrochlorothiazide
    lithium carbonate
    lithium citrate
    methimazole
    methotrexate
    methotrexate sodium
    telavancin
    thalidomide
    topiramate
    trastuzumab
    valproic acid
    warfarin
    Description

    Summary table assessment of the use of 26 drug products in the Mini-Sentinel Distributed Database (Warfarin, Ambrisentan, Bosentan, Dronedarone, Lisinopril, Lisinopril/Hydrochlorothiazide, Acitretin, Acitretin/Emollient Comb. 26, Isotretinoin, Methimazole, Methotrexate, Methotrexate Sodium, Clarithromycin, Fluconazole, Telavancin, Busulfan, Chlorambucil, Cyclophosphamide, Lenalidomide, Thalidomide, Trastuzumab, Topiramate, Valproic Acid, Lithium Carbonate, Lithium Citrate, and Finasteride). Note that the following generic names include NDC codes with both oral and injection/intravenous pathways: warfarin, methotrexate, busulfan, and cyclophoshamide. The generic name Telavancin was queried, but no results were generated for this drug product. Results were generated using the Mini-Sentinel Distributed Query Tool and the Dispensing Summary Table. Summary tables are precompiled stratified counts. Queries were executed in November 2011. This report includes information from 13 Data Partners.

    If you are using a web page screen reader and are unable to access this document, please contact the Mini-Sentinel Operations Center for assistance by clicking on the Submit Comments link above or sending an email requesting assistance to info@mini-sentinel.org.

    The information contained on this website is provided as part of FDA's commitment to place knowledge acquired from the Mini-Sentinel pilot in the public domain as soon as possible. Please read the disclaimer.

    Additional Details
    FDA Center
    CDER
    Time Period
    2004 - 2010
    Study Type
    Summary Table
    Assessment Type
    Exploratory Analyses
    Data Sources
    Mini-Sentinel Distributed Database (MSDD)